SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

401JK Crypto is trending as its highly engaged community rallies behind its unique narrative to challenge traditional retirement systems. Recent excitement is driven by its appearance in a major exchange's presentation and upcoming marketing campaigns, with many holders showcasing strong conviction through staking and a shared belief in its long-term potential.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid intense media M&A drama, as Paramount Skydance escalates its hostile bid for Warner Bros. Discovery, directly challenging Netflix's reported offer and raising concerns about potential regulatory hurdles. The ongoing uncertainty and perceived market "manipulation" are frustrating many investors, who are torn between fears of increased debt and the belief that the stock is "too cheap to ignore" ahead of its imminent earnings report.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is actively discussed following strategic shifts, including a new "Meta Compute" initiative focused on scaling AI infrastructure through significant nuclear energy partnerships, alongside reported workforce reductions in its Reality Labs division. The community is sharply divided, with some investors questioning the large capital expenditure and perceived lack of immediate returns, while others view these investments as essential for long-term growth and AI leadership.

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Travere Therapeutics Inc

Travere Therapeutics (TVTX) is highly volatile following its corporate update, which revealed the FDA requested additional clarification on clinical benefit for the FILSPARI label expansion in Focal Segmental Glomerulosclerosis (FSGS). This has triggered a significant sell-off as some investors anticipate a Complete Response Letter (CRL), while others view the drop as an overblown reaction, confidently buying the dip due to the company's strong existing IgA nephropathy (IgAN) drug sales and the potential for a first-ever FSGS therapy.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending following cautious 2026/2027 revenue guidance, largely driven by the anticipated impact of DefenCath's reimbursement shift in mid-2026, which triggered a sharp sell-off. The community is deeply divided, with many calling the plunge an "overreaction" and a buying opportunity given strong institutional ownership and pipeline potential. Others express frustration with management, viewing the guidance as conservative while anticipating future catalysts like the Kidney Care Access Protection Act and REZZAYO trial data.

Monero

Monero (XMR) is experiencing strong upward momentum and outperforming Bitcoin, capturing significant attention amid ongoing global discussions around privacy regulations and potential bans on privacy tokens. The community is actively touting XMR as the 'true privacy king' and the original vision for crypto, contrasting its robust privacy features with perceived compromises in other major digital assets. This surge reflects a growing community interest in uncensorable, genuinely private transactions, particularly as competitor ZCash faces challenges and some view XMR as an essential alternative.

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Biodesix Inc

Biodesix is trending sharply upward following its preliminary Q4 and full-year 2025 results, which reported strong revenue growth and reaffirmed positive adjusted EBITDA guidance. The community is actively discussing sustained momentum and further price appreciation, although some investors express caution regarding the company's cash position and potential future share dilution. This intense speculative interest, evidenced by massive trading volume, centers around the precision lung diagnostics firm.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

MannKind is trending due to recent optimistic business updates, highlighting record fourth-quarter revenue exceeding $100 million and several upcoming FDA decisions for Afrezza label updates and the FUROSCIX ReadyFlow Autoinjector. The community is actively debating the significant growth potential from these catalysts and the ongoing strategic importance of its partnership with United Therapeutics, contrasting with persistent concerns about leadership and past market performance.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is trending following a CFO transition and preliminary Q4 results, which showed robust user growth but also a strategic focus on product investment over immediate financial performance. This has ignited a debate among investors, with some viewing the significant price decline as an overreaction and a long-term buying opportunity, while others worry about AI disruption and the stock's future valuation.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is a trending topic amidst its J.P. Morgan conference presentation, the appointment of a Chief Commercial Officer, and recent publication of promising Phase 2 data for its obesity asset, VK2735. The community is debating whether these developments signal an imminent partnership or acquisition, leveraging the drug's "best-in-class" potential and significant market demand. However, some express frustration over perceived delays in FDA guidance and leadership's communication style, leading to varied sentiment on its competitive positioning in the lucrative metabolic therapies space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pagaya Technologies Ltd. (PGY) Stock Declines While Market Improves: Some Information for Investors

Pagaya Technologies Ltd. (PGY) concluded the recent trading session at $24.74, signifying a -4.96% move from its prior day's close.

Pagaya Technologies (NASDAQ:PGY) Shares Down 8.7% - Here's Why

Pagaya Technologies (NASDAQ:PGY) Stock Price Down 8.7% - Here's What Happened...

Alerus Financial (ALRS) Hit a 52 Week High, Can the Run Continue?

Alerus (ALRS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Pagaya to Participate in Upcoming Investor Conferences and Events

Pagaya Technologies Ltd. (Pagaya or the Company), a global technology company delivering AI-driven product solutions for the financial ecosystem, today announced that the Companys management team...

Pagaya Shines in 2025: How Should Investors Play the Fintech Stock?

PGY hit a 2025 inflection point with three straight GAAP profits, shrinking credit losses and a 125% share surge amid stronger fundamentals.

Pagaya Announces Timing of Fourth Quarter and Full Year 2025 Earnings Release

Pagaya Technologies (NASDAQ: PGY) intends to announce its fourth quarter and full year 2025 earnings on February 9, 2026. A conference call to discuss those earnings will be held on the same day at...

Insider Selling: Pagaya Technologies (NASDAQ:PGY) President Sells 3,945 Shares of Stock

Pagaya Technologies Ltd. (NASDAQ:PGY - Get Free Report) President Sanjiv Das sold 3,945 shares of Pagaya Technologies stock in a transaction on Monday, January 5th. The shares were sold at an average...

Zacks Investment Ideas feature highlights Pagaya, Eli Lilly and Weatherford 

Pagaya, Eli Lilly and Weatherford have been highlighted in this Investment Ideas article.

Pagaya Technologies (NASDAQ:PGY) President Sanjiv Das Sells 3,945 Shares

Pagaya Technologies Ltd. (NASDAQ:PGY - Get Free Report) President Sanjiv Das sold 3,945 shares of the firm's stock in a transaction dated Monday, January 5th. The stock was sold at an average price...

Pagaya Technologies (NASDAQ:PGY) CFO Evangelos Perros Sells 9,750 Shares

Pagaya Technologies Ltd. (NASDAQ:PGY - Get Free Report) CFO Evangelos Perros sold 9,750 shares of Pagaya Technologies stock in a transaction on Monday, January 5th. The stock was sold at an average...

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$24.74
Prev Close	$26.03
Open	$25.43
Dividend Yield	0.00%
50-Day Moving Average	$23.80
Beta	2.71
Avg. Volume	2.66M
PE Ratio	-9.25

52-Week High	$44.99
52-Week Low	$8.39
Market Capitalization	$2.09B
EPS (Annual)	-$5.66
Price to Book	4.52
Revenue Per Employee	$1.82M
Enterprise Value/EBITDA	N/A

PGY
Pagaya Technologies Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PGY News

PGYPagaya Technologies Ltd